Patents Assigned to Praecis Phamaceuticals, Inc.
  • Pharmaceutical formulations for sustained drug delivery
    Publication number: 20060193825
    Abstract: The present invention provides pharmaceutical formulations comprising a solid ionic complex of a polypeptide having an isoelectric point lower than physiological pH and an anionic carrier molecule. The formulations of the invention are suitable as depot formulations for the sustained release of therapeutic polypeptides.
    Type: Application
    Filed: November 2, 2005
    Publication date: August 31, 2006
    Applicant: Praecis Phamaceuticals, Inc.
    Inventors: Gary Musso, Nicholas Barker, Janet Wolfe, Ming Ye
  • Methods and compositions for modulating sphingosine-1-phosphate (S1P) receptor activity
    Publication number: 20060135786
    Abstract: The present invention relates to compounds which modulate the activity of the S1P1 receptor, the use of these compounds for treating conditions associated with signaling through the S1P1 receptor, and pharmaceutical compositions comprising these compounds.
    Type: Application
    Filed: August 12, 2005
    Publication date: June 22, 2006
    Applicant: Praecis Phamaceuticals, Inc.
    Inventors: Ashis Saha, Malcolm Kavarana, Ghotas Evindar, Alexander Satz, Barry Morgan